5.53 (-%)
As of Nov 21, 2024
Source:
Kazia Therapeutics Ltd has been pharmaceutical drug development. The Company is an emerging oncology-focused biotechnology company that has a portfolio of development candidates, diversified across several distinct technologies, with the potential to yield first-in-class and best-in-class agents in a range of oncology indications.
| Country | United States |
| Headquarters | sydney nsw |
| Phone Number | 01161298780088 |
| Industry | manufacturing |
| CEO | Dr John Friend |
| Website | www.kaziatherapeutics.com |